CD19 Rituximab

This protocol provides the client with a CD19 and CD20 B panel for the monitoring of rituximab treatment.
Clinical details: 
Rituximab is a chimeric anti-human monoclonal antibody that reacts with the CD20 antigen and is used to treat B cell lymphoma in the adult. It is also used to treat moderate-to-severe forms of Rheumatoid arthritis and other diseases involving the immune system.
Synonyms or keywords: 
CD19 Rituximab protocol, CLL, Rheumatoid arthritis, Immunophenotyping Rituximab monitoring.
Sample type and Volume required: 
EDTA Whole Blood 1ml
Turnaround time: 
48 hours
Special sample instructions: 

Do not refrigerate samples

Storage and transport: 
Store and transport samples at room temperature. Maximum sample age for analysis is 48hrs.
Special Haematology Department at Guy's and St Thomas' Hospital
St Thomas’ Hospital
5th Floor - North Wing
Westminster Bridge Road
London SE1 7EH
Telephone - 0207 188 8189

Guy’s Hospital
4th Floor - Southwark Wing
Great Maze Pond
London SE1 9RT
Telephone - 020 7188 3421

Flow Cytometry/Immunophenotyping Laboratory at Guy's and St Thomas' Clinical Advisory Service
Monday - Friday 9:00 - 17:00
For clinical advice or interpretation of results, please contact the laboratory in the first instance.

Print as a PDF

Last updated: 13/08/2019